Free Alerts   Login

DNMR Stock Price Correlated With Danimer Scientific Financials

DNMR Stock Price vs. Quarterly
Income Statement
Cash Flow
Balance Sheet

DNMR Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

DNMR Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

DNMR Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Value (x$1000)
increase or decrease
6,248,580 sh
403,156 sh
Vanguard Group
5,020,156 sh
-4,826 sh
Greenlight Capital
2,734,580 sh
131,890 sh
Jefferies Financial Group.
2,541,946 sh
2,236,846 sh
Geode Capital Management
1,876,486 sh
67,139 sh
1,835,712 sh
-178,039 sh
State Street
1,834,118 sh
-19,395 sh
Capital Investment Advisors
787,650 sh
-250 sh
Susquehanna International Group,
Call options for 734,900 sh
734,900 sh
Royal Bank Of Canada
718,687 sh
13,955 sh
684,070 sh
-17,580 sh
Charles Schwab Investment Management
637,079 sh
-65,493 sh
Jefferies Financial Group.
Put options for 593,100 sh
593,100 sh
Zacks Investment Management
503,335 sh
-44,628 sh
Graham Capital Management, L.P.
500,000 sh
Renaissance Technologies
498,700 sh
498,700 sh
Goldman Sachs Group
454,841 sh
16,994 sh
Nuveen Asset Management
411,959 sh
30,721 sh
406,357 sh
8,593 sh
First Manhattan
375,000 sh
Note 1. Basis of Presentation Description of Business Danimer Scientific, Inc., together with its subsidiaries (“Company” , “Danimer”, “we”, “us”, or “our”), is a performance polymer company specializing in bioplastic replacements for traditional petroleum-based plastics. Our common stock is listed on the New York Stock Exchange under the symbol “DNMR”. The Company (formerly Live Oak Acquisition Corp. (“Live Oak”)), was originally incorporated in the State of Delaware on May 24, 2019 as a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses. Live Oak completed its initial public offering in May 2020. On December 29, 2020, Live Oak consummated a business combination (“Business Combination”) pursuant to an Agreement and Plan of Merger, dated as of October 3, 2020 (as amended by Amendment No. 1, dated as of October 8, 2020, and Amendment No. 2, dated as of December 11, 2020 (collectively “Merger Agreement”), by and among Live Oak, Green Merger Corp. (“Merger Sub.”), and Meredian Holdings Group, Inc. (“Legacy Danimer”). Immediately upon consummation of the Business Combination, Merger Sub. merged with and into Legacy Danimer, with Legacy Danimer surviving the merger as a wholly owned subsidiary of Live Oak. In connection with the Business Combination, Live Oak changed its name to Danimer Scientific, Inc. On August 11, 2021, we closed the acquisition of Novomer, Inc. (integrated into our business as “Danimer Catalytic Technologies”). Our consolidated results include those of Danimer Catalytic Technologies from the acquisition date forward. Refer to Note 2 for further discussion of the acquisition. Financial Statements The accompanying condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and consolidate all assets and liabilities of the Company and its wholly owned subsidiaries. GAAP requires us to make certain estimates and assumptions in recording assets, liabilities, sales and expenses as well as in the disclosure of contingent assets and liabilities. Actual results could differ from those estimates. All intercompany transactions and balances have been eliminated. Certain reclassifications have been made to previously reported amounts to conform to the current presentation. In preparing these condensed consolidated financial statements, we have considered and, where appropriate, included the effects of the COVID-19 pandemic on our operations. The pandemic continues to provide significant challenges to the U.S. and global economies. Since we do no t have any items of other comprehensive income or loss, there is no difference between net loss and comprehensive (loss) income for the three month periods ended March 31, 2022 or 2021, so a separate Statement of Comprehensive Income (Loss) that would otherwise be required is not presented. Recently Issued Accounting Pronouncements There have been no new accounting pronouncements not yet effective that we believe will have a significant effect, or potential significant effect, on our condensed consolidated financial statements.

Free historical financial statements for Danimer Scientific Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 11 quarters since 2021. Compare with DNMR stock chart to see long term trends.

Data imported from Danimer Scientific Inc. SEC filings. Check original filings before making any investment decision.